EarningsQ4 2023 Earnings Report

BioMarin Pharmaceutical (BMRN) Q4 2023 Earnings Report

0 Followers

MX:BMRN Q4 2023 EPS Results

Actual EPS$2.00

Consensus EPS$3.58

Beat/MissMissed by -$1.58

One Year Ago EPS$0.00

Actual Revenue$11.73B

Expected Revenue$11.60B

Beat/MissBeat by +$128.68M

YoY Revenue Growth+25.23%

QuarterQ4 2023

Date02/22/2024

TimeAfter Close

Conference CallThursday, February 22, 2024

MX:BMRN Upcoming Earnings

BioMarin Pharmaceutical's next earnings date is estimated for November 3, 2026, based on past reporting schedules.

MX:BMRN Q4 2023 Earnings Call

0:00 / 0:00

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Nov 03, 2026	2026 (Q3)	24.25 / -	-2.906	―
Aug 06, 2026	2026 (Q2)	17.20 / 21.79	22.34	-2.44% (-0.54)
May 04, 2026	2026 (Q1)	12.57 / 13.80	17.254	-20.00% (-3.45)
Feb 23, 2026	2025 (Q4)	3.07 / -4.36	11.624	-137.50% (-15.98)
Oct 27, 2025	2025 (Q3)	-5.09 / -2.91	9.989	-129.09% (-12.90)
Aug 04, 2025	2025 (Q2)	15.64 / 22.34	9.989	123.64% (+12.35)
May 01, 2025	2025 (Q1)	12.97 / 17.25	8.355	106.52% (+8.90)
Feb 19, 2025	2024 (Q4)	9.70 / 11.62	1.998	481.82% (+9.63)
Oct 29, 2024	2024 (Q3)	9.64 / 9.99	3.814	161.90% (+6.18)
Aug 05, 2024	2024 (Q2)	6.50 / 9.99	5.267	89.66% (+4.72)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed